Dave Muoio

AI is steadily proving itself to the clinical community, but there are some aspects of care in which an algorithm will never be granted full control, said Cardiologs CEO Yann Fleureau.

A bipartisan quartet of lawmakers wrote to Congressional leaders on the need to deliver additional funds through the longstanding Rural Health Care Program.

Following a virtual consultation, both companies are supplying Rutgers Clinical Genomics Laboratory's saliva-based molecular test to consumers at $150 per kit.

Downloaded and used by millions of U.K. and U.S. residents, the study app provided data on which symptoms are associated with confirmed cases, and roughly how many untested users likely have the disease.

Lucid Lane combines regular virtual coaching with mobile, data-driven care plans.

The proposed legislation would make companies seek consent from consumers before collecting personal data to track COVID-19, among other data privacy requirements. No Democratic senators have attached themselves to the bill.

The in-person and virtual primary care provider has tripled its staff over the last few months.

"Remote monitoring is here to stay," CEO Zane Burke said during yesterday's earnings call.

The startup, which specializes in a range of at-home testing kits, so far only offers a COVID-19 testing product for point-of-care providers.

The Fitbit Heart Study is looking to enroll 200,000 to 250,000 device owners, and will support clinical evaluation and regulatory submissions of the company's PPG atrial fibrillation algorithm.